NPS Pharmaceuticals (Nasdaq: NPSP) reports a Q1 loss of $0.83, 20 cents better than estimates.(-1.03) Revenues were $6.1 million ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE